<![CDATA[Sucampo Pharmaceuticals Inc. | Company News & Executive Profiles - SCMP | BNET]]> en-us <![CDATA[Sucampo Pharmaceuticals, Inc.Q2 2009 Earnings Call Transcript]]> Thu, 06 Aug 2009 19:10:39 -0700 SCMP SCMP <![CDATA[Sucampo Pharmaceuticals, Inc.Q2 2009 Earnings Call Transcript]]> Thu, 06 Aug 2009 08:10:39 -0700 SCMP SCMP <![CDATA[Sucampo Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript]]> Fri, 08 May 2009 17:49:12 -0700 SCMP SCMP <![CDATA[Sucampo Pharmaceuticals, Inc. Q4 2008 Earnings Call Transcript]]> Thu, 19 Feb 2009 15:43:17 -0800 SCMP SCMP <![CDATA[Sucampo Pharmaceuticals Inc. Q3 2008 Earnings Call Transcript]]> Wed, 12 Nov 2008 19:16:13 -0800 SCMP SCMP <![CDATA[Sucampo Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript]]> Mon, 18 Aug 2008 12:01:12 -0700 SCMP SCMP <![CDATA[Sucampo Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript]]> Mon, 26 May 2008 10:24:11 -0700 SCMP SCMP <![CDATA[Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD).]]> Thu, 13 Sep 2007 23:59:59 -0700 SCMP SCMP <![CDATA[American Motility Society Announces Program to Provide Advanced Clinical Training in Neurogastroenterology and GI Motility at Centers of Excellence]]> Tue, 24 Oct 2006 23:59:59 -0700 SCMP SCMP <![CDATA[Study Demonstrated AMITIZA(TM) (lubiprostone) Showed Efficacy Within 24 and 48 Hours of Treatment]]> Mon, 23 Oct 2006 23:59:59 -0700 SCMP SCMP